Regulatory FDA freezes CRL trove as ‘radical transparency’ push hits speedbump BioSpaceAn unnamed pharma filed a citizen petition in April seeking reforms to the way the FDA publicly releases rejection letters, alleging that the policy...Read full story pharminent July 9, 2026 (Last updated: July 9, 2026) BioSpace An unnamed pharma filed a citizen petition in April seeking reforms to the way the FDA publicly releases rejection letters, alleging that the policy… Read full story Post navigation Previous: NICE aims to cut funding for Amgen lung cancer drug LumykrasNext: GSK ends dementia alliance with Alector after setbacks Related Stories Regulatory Bayer’s Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion pharminent September 10, 2026 Regulatory HHS appoints permanent FDA CBER, CDER heads pharminent September 10, 2026 Regulatory FDA approves AstraZeneca’s Etcamah combo for advanced breast cancer pharminent September 7, 2026